Sofpironium topical gel, 12.45%, for the treatment of axillary hyperhidrosis: Pooled efficacy and safety results from 2 phase 3 randomized, controlled, double-blind studies Article

publication date

  • July 1, 2025

webpage

published in

keywords

  • anticholinergic
  • axillary hyperhidrosis
  • sofpironium

start page

  • 82

end page

  • 88

volume

  • 93

issue

  • 1